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Early after the turn of the century, much excitement was
generated by the reports of Tillerson et al. [1, 2] that
exercise appeared to protect against neuronal degeneration
in rodent models of toxin-induced parkinsonism. Such find-
ings, coupled with epidemiologic suggestions that persons
with a history of moderate to vigorous exercise may have a
decreased risk of developing Parkinson’s disease (PD) [3–5],
led to an exponential growth in research on the effects of
physical activity and exercise on PD. Unfortunately, addi-
tional follow-up animal studies to the work of Tillerson et al.
have failed to yield consistent findings [6–10]. For this
reason, it appears that the critical factors associated with
neuroprotection remain elusive. With a continued focus
on examining the effects of exercise in animal models of
parkinsonism, identifying biomarkers of disease progression,
and new and innovative outcomes, we look forward to a
day when an evidence-based neuroprotection study can be
implemented in human idiopathic PD.
Although results from studies of the neuroprotective
effects of exercise are mixed, one consistent finding from
animal models and human trials is the lack of adverse effects
of exercise and physical activity on anatomic and behavioral
outcomes. The adverse side-effect profile of exercise as an
intervention for those with PD appears to be minimal. As
such, we think there is no reason to wait for confirmation
of neuroprotection. Rather, evidence is accumulating that
exercise and physical activity should be utilized as key tools
in the management of PD across the spectrum of disease.
Evidence-based approaches to rehabilitation are known to
improve physical functioning, strength, balance, gait, and
health-related quality of life among people with PD [11–13],
but questions remain about whether or not these approaches
can substantially impact fall rates [14–16]. This is a key
issue, as most individuals with PD are only referred to
rehabilitation after the onset of reduced mobility and an
increase in falls. As such, the majority of PD rehabilitation
care is provided in a tertiary prevention model of care.
People with PD are most often not seen earlier in the course
of the disease, when rehabilitation could play a key role
in secondary preventive care. Secondary prevention would
entail addressing early PD signs and symptoms, ideally
immediately upon diagnosis, to optimize the condition of the
central nervous system as well as other peripheral systems
such as the cardiovascular and respiratory systems in order
to maximize function and slow progression of disability.
Even earlier intervention should be considered, as we think
that rehabilitation may ultimately serve a role in primary
prevention of PD. Primary prevention would entail treating
those without current neurologic signs and symptoms in
order to prevent PD from ever developing. Those who are
potentially at risk for PD (e.g., leucine-rich repeat kinase
2 (LRRK2) carriers, those with rapid eye movement sleep
behavior disorder, anosmia, constipation, abnormal positron
emission tomography (PET) scans, etc.) may be excellent
candidates for primary prevention.
The presently limited scope of rehabilitation in the
management of PD, with utilization of rehabilitation as
mainly a tertiary prevention measure, reflects a missed
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opportunity on the part of healthcare providers, patient
advocacy groups, and patients themselves. All stakeholders
in this situation should be advocates for higher expectations
and should work together to develop targets for the future
of rehabilitation in PD to include primary and secondary
prevention and to improve our current provision of tertiary
prevention interventions.
From the Spectrum of Rehabilitation Options to Atypical
Parkinsonism. In this special issue are several articles that we
hope advance the field and move us closer to these future
targets. The issue opens with a series of three review articles.
The first paper summarizes and synthesizes the nature and
features of previous randomized, controlled trials of exercise
or motor training in PD, important for the long-term
provision of increasing levels of physical activity. The second
paper provides a meta-analysis focused on motor learning in
upper extremity tasks. The third paper provides an integrated
overview of the Lee Silverman Voice Treatment approach
to voice and movement therapy, discussing the rationale
for the approach as well as the data regarding efficacy.
These opening three articles highlight the important roles of
speech, occupational, and physical therapy approaches in the
rehabilitation of individuals with PD as well as address areas
for future research.
Several papers in this special issue relate to gait, balance,
and falls, examining the relationship between gait economy
and six-minute walk distance, reviewing the literature on the
costs of dual-task walking, and providing a new theoretical
framework for considering freezing of gait (FOG) including
methods to improve overall locomotor performance and
methods to target the triggers of FOG. Also included are two
randomized, controlled trials designed to improve walking.
One compares visually cued walking training on a treadmill
to overground walking; the other examines use of rotating
treadmill training as a means of improving turning, thereby
targeting a known trigger of FOG. Turning is also examined
in a paper that describes turning impairments in early PD.
This is followed by a paper examining the effects of medica-
tions on gait-related mobility and postural control, showing
that although pharmacologic intervention enhanced some
aspects of mobility, reactive postural responses did not
improve. This highlights the need for awareness of postural
control deficits and the need to be able to measure these
deficits, as is addressed by the next two papers in the issue
that present the relative merits of different balance measures
across different levels of PD severity and examine the relative
effectiveness of different balancemeasures for prospective fall
prediction.
The inextricable link between posture and gait is
addressed in a paper that focuses on the coupling of posture
and locomotion and suggests this coupling as a specific
target for rehabilitation. This link is also highlighted in
two papers demonstrating that walking ability is a major
contributor to fear of falling in PD, as is knee strength. The
latter leads to the suggestion that resistance training may
therefore be warranted as an approach to reduce fear of
falling. The rationale for progressive resistance training as
well as its potential mechanisms are addressed in a review
paper, followed by an article examining the reliability of one
repetition maximum strength testing in PD.
We conclude the issue with a set of papers addressing
the delivery of evidence-based rehabilitation in different
settings. These papers include two that are randomized,
controlled trials of physiotherapy in outpatient and home-
based settings, respectively. These are followed by a paper
examining facilitators and barriers to community-based
walking exercise among those with PD. Community-based
healthcare for PD is also addressed in a paper describing
the steps taken to improve the Dutch model of multidisci-
plinary care. The final paper of the issue demonstrates the
effectiveness of multidisciplinary care in an inpatient setting
in persons with atypical parkinsonism. All papers in this
final section draw attention to the need for a collaborative,
cooperative approach to rehabilitation across disciplines,
across settings, and with PD and other related disorders.
Ultimately, we believe that there is a need to redefine
the role of rehabilitation in PD to include the provision
of primary, secondary, and tertiary prevention approaches.
Across this spectrum from primary through tertiary care,
the application of multidisciplinary approaches is needed
to optimize the health, function, and quality of life of
individuals at risk for, or who already have, PD. Only then
will the full potential of rehabilitation in the management of
PD be realized.
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